Timothy P. Clackson

2022

In 2022, Timothy P. Clackson earned a total compensation of $4.4M as President, Chief Executive Officer and Director at Theseus Pharmaceuticals, a 38% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$313,500
Option Awards$3,451,050
Salary$570,000
Other$16,790
Total$4,351,340

Clackson received $3.5M in option awards, accounting for 79% of the total pay in 2022.

Clackson also received $313.5K in non-equity incentive plan, $570K in salary and $16.8K in other compensation.

Rankings

In 2022, Timothy P. Clackson's compensation ranked 764th out of 5,625 executives tracked by ExecPay. In other words, Clackson earned more than 86.4% of executives.

ClassificationRankingPercentile
All
764
out of 5,625
86th
Division
Manufacturing
343
out of 3,053
89th
Major group
Chemicals And Allied Products
111
out of 1,380
92nd
Industry group
Drugs
98
out of 1,281
92nd
Industry
Pharmaceutical Preparations
72
out of 927
92nd
Source: SEC filing on April 26, 2023.

Clackson's colleagues

We found two more compensation records of executives who worked with Timothy P. Clackson at Theseus Pharmaceuticals in 2022.

2022

William Shakespeare

Theseus Pharmaceuticals

Co-Founder

2022

David Kerstein

Theseus Pharmaceuticals

Chief Medical Officer

News

In-depth

You may also like